Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients.
Gitto S, Vizzutti F, Baldi S, Campani C, Navari N, Falcini M, Venturi G, Montanari S, Roccarina D, Arena U, Pallecchi M, Di Bonaventura C, Bartolucci G, Ramazzotti M, Citone M, Fanelli F, Amedei A, Marra F. Gitto S, et al. Among authors: di bonaventura c. Dig Liver Dis. 2023 May;55(5):622-628. doi: 10.1016/j.dld.2022.11.017. Epub 2022 Dec 16. Dig Liver Dis. 2023. PMID: 36529635
Pattern of macrovascular invasion in hepatocellular carcinoma.
Guarino M, Cucchetti A, Pontillo G, Farinati F, Benevento F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Rodolfo S, Cabibbo G, Marra F, Mega A, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Giannini EG, Morisco F; ITA.LI.CA Group. Guarino M, et al. Eur J Clin Invest. 2021 Jul;51(7):e13542. doi: 10.1111/eci.13542. Epub 2021 Mar 23. Eur J Clin Invest. 2021. PMID: 33755196
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status.
Aspite S, Schepis F, Roccarina D, Gitto S, Citone M, Di Bonaventura C, Bianchini M, Arena U, Vannucchi AM, Guglielmelli P, Campani F, Fanelli F, Marra F, Vizzutti F. Aspite S, et al. Among authors: di bonaventura c. Liver Int. 2022 Feb;42(2):419-424. doi: 10.1111/liv.15148. Epub 2022 Jan 7. Liver Int. 2022. PMID: 34963020
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, Senzolo M, Nardelli S, Miraglia R, Roccarina D, Campani C, Saltini D, Caporali C, Indulti F, Gitto S, Zanetto A, Di Maria G, Bianchini M, Pecchini M, Aspite S, Di Bonaventura C, Citone M, Guasconi T, Di Benedetto F, Arena U, Fanelli F, Maruzzelli L, Riggio O, Burra P, Colecchia A, Villa E, Marra F, Cammà C, Schepis F. Vizzutti F, et al. Among authors: di benedetto f, di bonaventura c, di maria g. Hepatology. 2023 Feb 1;77(2):476-488. doi: 10.1002/hep.32704. Epub 2022 Aug 17. Hepatology. 2023. PMID: 35921493
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
Vitale A, Romano P, Cillo U; Writing Group for the HE.RC.O.LE.S Collaborative Group; Writing Group for the ITA.LI.CA Collaborative Group; HE.RC.O.LE.S and ITA.LI.CA Collaborative Groups; Lauterio A, Sangiovanni A, Cabibbo G, Missale G, Marseglia M, Trevisani F, Foschi FG, Cipriani F, Famularo S, Marra F, Saitta C, Serenari M, Vidili G, Morisco F, Caturelli E, Mega A, Pelizzaro F, Nicolini D, Ardito F, Garancini M, Masotto A, Baroni GS, Azzaroli F, Giannini E, Perri P, Scarinci A, Fontana AP, Brunetto MR, Iaria M, Di Marco M, Nardone G, Dominioni T, Lai Q, Ferrari C, Rapaccini GL, Rodolfo S, Romano M, Conci S, Zoli M, Conticchio M, Zanello M, Zimmitti G, Fumagalli L, Troci A, Germani P, Gasbarrini A, La Barba G, De Angelis M, Patauner S, Molfino S, Zago M, Pinotti E, Frigo AC, Baiocchi GL, Frena A, Boccia L, Ercolani G, Tarchi P, Crespi M, Chiarelli M, Abu Hilal M, Cescon M, Memeo R, Ruzzenente A, Zanus G, Griseri G, Rossi M, Maestri M, Della Valle R, Ferrero A, Grazi GL, Romano F, Giuliante F, Vivarelli M, Jovine E, Torzilli G, Aldrighetti L, De Carlis L. Vitale A, et al. JAMA Surg. 2024 May 15:e241184. doi: 10.1001/jamasurg.2024.1184. Online ahead of print. JAMA Surg. 2024. PMID: 38771633
Correction to: Brivaracetam use in clinical practice: a Delphi consensus on its role as first add‑on therapy in focal epilepsy and beyond.
Lattanzi S, Chiesa V, Di Gennaro G, Ferlazzo E, Labate A, La Neve A, Meletti S, Di Bonaventura C; Consensus Collaborators Group. Lattanzi S, et al. Among authors: di bonaventura c. Neurol Sci. 2024 Apr 11. doi: 10.1007/s10072-024-07526-4. Online ahead of print. Neurol Sci. 2024. PMID: 38600333 No abstract available.
Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication.
Cerulli Irelli E, Cocchi E, Morano A, Gesche J, Caraballo RH, Lattanzi S, Strigaro G, Rosati E, Catania C, Ferlazzo E, Casciato S, Di Gennaro G, Pizzanelli C, Giuliano L, Viola V, Mostacci B, Pignatta P, Fortunato F, Pulitano P, Panzini C, Gambardella A, Atalar AÇ, Labate A, Operto FF, Giallonardo AT, Baykan BB, Beier CP, Di Bonaventura C; for Women with Epilepsy Treatment Options and Research (WETOR) study group. Cerulli Irelli E, et al. Among authors: di bonaventura c. Neurology. 2024 May;102(9):e209222. doi: 10.1212/WNL.0000000000209222. Epub 2024 Apr 3. Neurology. 2024. PMID: 38569127
187 results